BLUE SCORPION GROUP INC. · NDC 87019-001-01

18 Years of Research. Two
International Patents. One
Protocol Available to You Today.

 

Escozul® is a wellness protocol developed around blue scorpion biological compounds and supported by scientific research, published studies, and international intellectual property development by our scientific research group, led by Dr. Alexis Diaz.

Listed in the U.S. FDA National Drug Code (NDC) Directory · 28 Published Scientific Articles · 5 International Research Agreements.

28

Published Articles

FDA NDC

Listed

+600

Documented
Cases

5

Research
Agreements

2

Patent Applications
WIPO  Nov 2025 

The Formulation

Not a supplement. A structured wellness protocol.

 

Escozul® is a bioactive formulation developed from selected fractions of blue scorpion venom and supported by more than 18 years of scientific research and published studies.

It is provided exclusively as part of a structured wellness protocol that includes personalized evaluation, dedicated advisor support, and continuous follow-up throughout your process.

Our approach is designed to ensure that every patient receives guidance, orientation, and ongoing support from our team.

LEAD RESEARCHER

The world's leading authority on blue scorpion compounds

 

Dr. Alexis Diaz has dedicated 18 years exclusively to the study of
blue scorpion venom fractions. Author of 25+ published
scientific articles. Co-inventor of two international patent
applications filed under PCT with WIPO.

+18 Years of Research
+25 Published Articles
2 PCT Patent Applications
5 International Research
Agreements

SCIENTIFIC PUBLICATIONS

Peer-reviewed in high-impact international journals.

PHARMACOLOGY TODAY • 2025

The venom of the Rhopalurus junceus scorpion induces cell cycle arrest at the G2/M phase and apoptotic cell death in human non-small cell lung cancer cell lines In this study, blue scorpion venom was tested on human non-small cell lung cancer cells. The scientists found that the venom halted the proliferation of cancer cells and triggered apoptosis, which is programmed cell death.
VIEW POST

FRONTIERS 2020

Ion channels are emerging as promising targets in cancer research because they regulate tumor growth and spread. Scorpion venom contains peptide toxins that can modulate these channels, making them potential candidates for the development of future anticancer therapies.

VIEW POST

CANCER REPORTS • 2026

Acute Oral Toxicity and Genotoxicity of Heteroctenus junceus Scorpion Venom This study evaluated the safety of blue scorpion venom administered orally. The results showed low acute toxicity, and no significant evidence of genetic damage was found in the tests conducted.
VIEW POST

INTELLECTUAL PROPERTY

Two international patent applications.
Published by WIPO. November 2025

PCT

WO2025241039

Pharmaceutical compositions based on venom fractions — fractions F4 and F5.3

Nov 27, 2025

WIPO

"Patent applications filed under PCT, published by WIPO. Currently in evaluation phase — not yet granted. NDC registration and patent status are independent. Neither implies FDA approval."

PCT

WO2025241040

Derived peptides, structural variants, methods and pharmaceutical uses

Nov 27, 2025

WIPO

"Patent applications filed under PCT, published by WIPO. Currently in evaluation phase — not yet granted. NDC registration and patent status are independent. Neither implies FDA approval."

Choose Your Cycle

Choose your protocol cycle

Every cycle includes the formulation, dedicated advisor support, and your personal
baseline profile. Ships from Miami in 2-3 business days.

3 Month

Ideal for First-time participants

$450

$150 / Month

6 Month

Ideal for Complete protocol
experience

$750

$125 / Month (Save $150)

12 Month

Ideal for First-time participants

$900

$75/ Month (Save $900)

Secure checkout via Clover (credit/debit card)
Also accepted:  Zelle & Venmo

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Results may vary.

DEDICATED SUPPORT

You don't navigate this alone

From the moment you complete your order, you have access to a dedicated advisor who guides you through every stage of the protocol — in English, with direct communication via WhatsApp and email.
 

After your purchase, you’ll be asked to share your relevant health background, when voluntarily provided. This allows our team to build your personal baseline profile — a reference point to track and compare your progress throughout the entire cycle.

Available Monday-Friday · Response within 24 hours

Order your cycle

Select your 3, 6, or 12-month cycle and complete your purchase securely online.

Share your baseline records

After purchase, submit your relevant health background, when voluntarily provided to create your personal starting profile.

Advisor reaches out within 24h

Your dedicated English-speaking advisor contacts you via WhatsApp to begin the protocol.

Ongoing follow-up throughout

Regular check-ins, questions answered, and documented progress compared to your baseline.

TRACK RECORD

600+ documented cases. 20+ years of follow-up

Every person who has gone through the Escozul® protocol has been individually evaluated, followed
and documented by our research team. These records form part of our ongoing scientific work.

600+

Documented Cases

Individual cases evaluated, followed and documented over 20+ years.

15+

Years of Follow-Up

Long-term documented follow-up spanning more tan 15 years.

28

Scientific Publications

Peer-reviewed publications on blue scorpion venom fractions.

Ready to start your Escozul® protocol?

 

Every person who has gone through the Escozul® protocol has been individually evaluated, followed
and documented by our research team. These records form part of our ongoing scientific work.